RGD (Arg-Gly-Asp) Peptides |
| رقم الكتالوجGC10184 |
RGD (Arg-Gly-Asp) الببتيدات هو ثلاثي الببتيد الذي يؤدي بشكل فعال إلى التصاق الخلية ، ويتعامل مع خطوط خلوية معينة ويثير استجابات خلوية محددة ؛ يرتبط بالإنتجرينات.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 99896-85-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
RGD (Arg-Gly-Asp) Peptides is a tripeptide that can bind to integrins, effectively induce cell adhesion, locate a specific cell line and produce a specific cellular response[1]. RGD (Arg-Gly-Asp) Peptides regulates cell adhesion, migration and signal transduction by competitively binding to the integrin ligand binding domain[2]. RGD (Arg-Gly-Asp) Peptides can be chemically modified (such as cyclization, conjugation) to expand its application in drug delivery, imaging diagnosis and other fields[3, 4]. RGD (Arg-Gly-Asp) Peptides are widely used in cancer targeted therapy, tissue engineering and cardiovascular disease research[5].
References:
[1] Sheu J R, Lin C H, Peng H C, et al. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells[J]. Proceedings of the Society for Experimental Biology and Medicine, 1996, 213(1): 71-79.
[2] Takagi J. Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins[J]. Biochemical Society Transactions, 2004, 32(3): 403-406.
[3] Battistini L, Bugatti K, Sartori A, et al. RGD peptide‐drug conjugates as effective dual targeting platforms: recent advances[J]. European Journal of Organic Chemistry, 2021, 2021(17): 2506-2528.
[4] Lee S, Xie J, Chen X. Peptides and peptide hormones for molecular imaging and disease diagnosis[J]. Chemical reviews, 2010, 110(5): 3087-3111.
[5] Zhao J, Santino F, Giacomini D, et al. Integrin-targeting peptides for the design of functional cell-responsive biomaterials[J]. Biomedicines, 2020, 8(9): 307.
| Cas No. | 99896-85-2 | SDF | |
| Canonical SMILES | C(CC(C(=O)NCC(=O)NC(CC(=O)O)C(=O)O)N)CN=C(N)N | ||
| Formula | C12H22N6O6 | M.Wt | 346.34 |
| الذوبان | ≥ 17.3mg/mL in Water with gentle warming | Storage | Store at -20°C,stored under nitrogen |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.8873 mL | 14.4367 mL | 28.8734 mL |
| 5 mM | 0.5775 mL | 2.8873 mL | 5.7747 mL |
| 10 mM | 0.2887 mL | 1.4437 mL | 2.8873 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >97.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 21 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *